European Medicines Agency approval summary: Zaltrap for the treatment of patients with oxaliplatin-resistant metastatic colorectal cancer-Reference-Cited by-同舟云学术

European Medicines Agency approval summary: Zaltrap for the treatment of patients with oxaliplatin-resistant metastatic colorectal cancer

Published:2017 Issue:2 Volume:2 Page:e000190
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Stanel Stefan Cristian,Sjöberg Jan,Salmonson Tomas,Foggi Paolo,Caleno Mariapaola,Melchiorri Daniela,Gravanis Iordanis,Tzogani Kyriaki,Pignatti Francesco

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference16 articles.

1. Metastatic colorectal Cancer: esmo clinical practice guidelines for diagnosis, treatment and follow-up;Van Cutsem;Ann Oncol,2014

2. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal Cancer: a randomized GERCOR study;Tournigand;J Clin Oncol,2004

3. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer;Goldberg;J Clin Oncol,2004

4. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

5. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal Cancer: results from the eastern cooperative oncology group study E3200;Giantonio;J Clin Oncol,2007

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VEGF signaling: Role in angiogenesis and beyond;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03

2. Anti-angiogenic Drug Resistance: Roles and Targeting of Non-coding RNAs (microRNAs and long non-coding RNAs);Current Molecular Pharmacology;2023-12

3. Novel N -Arylmethyl-aniline/chalcone hybrids as potential VEGFR inhibitors: synthesis, biological evaluations, and molecular dynamic simulations;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-11-20

4. A different approach to immunochemotherapy for colon Cancer: Development of nanoplexes of cyclodextrins and Interleukin-2 loaded with 5-FU;International Journal of Pharmaceutics;2022-07

5. Exosomal miR-301a-3p from esophageal squamous cell carcinoma cells promotes angiogenesis by inducing M2 polarization of macrophages via the PTEN/PI3K/AKT signaling pathway;Cancer Cell International;2022-04-18